Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1
- PMID: 12832613
- PMCID: PMC166252
- DOI: 10.1073/pnas.1032913100
Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1
Abstract
Type 2 diabetes mellitus (DM) is characterized by insulin resistance and pancreatic beta cell dysfunction. In high-risk subjects, the earliest detectable abnormality is insulin resistance in skeletal muscle. Impaired insulin-mediated signaling, gene expression, glycogen synthesis, and accumulation of intramyocellular triglycerides have all been linked with insulin resistance, but no specific defect responsible for insulin resistance and DM has been identified in humans. To identify genes potentially important in the pathogenesis of DM, we analyzed gene expression in skeletal muscle from healthy metabolically characterized nondiabetic (family history negative and positive for DM) and diabetic Mexican-American subjects. We demonstrate that insulin resistance and DM associate with reduced expression of multiple nuclear respiratory factor-1 (NRF-1)-dependent genes encoding key enzymes in oxidative metabolism and mitochondrial function. Although NRF-1 expression is decreased only in diabetic subjects, expression of both PPAR gamma coactivator 1-alpha and-beta (PGC1-alpha/PPARGC1 and PGC1-beta/PERC), coactivators of NRF-1 and PPAR gamma-dependent transcription, is decreased in both diabetic subjects and family history-positive nondiabetic subjects. Decreased PGC1 expression may be responsible for decreased expression of NRF-dependent genes, leading to the metabolic disturbances characteristic of insulin resistance and DM.
Figures
Similar articles
-
Gene expression in humans with diabetes and prediabetes: what have we learned about diabetes pathophysiology?Curr Opin Clin Nutr Metab Care. 2004 Jul;7(4):383-90. doi: 10.1097/01.mco.0000134359.23288.72. Curr Opin Clin Nutr Metab Care. 2004. PMID: 15192439 Review.
-
Gene expression in the pathophysiology of type 2 diabetes mellitus.Curr Diab Rep. 2004 Jun;4(3):176-81. doi: 10.1007/s11892-004-0020-x. Curr Diab Rep. 2004. PMID: 15132881 Review.
-
Transcriptional profiling of myotubes from patients with type 2 diabetes: no evidence for a primary defect in oxidative phosphorylation genes.Diabetologia. 2008 Nov;51(11):2068-77. doi: 10.1007/s00125-008-1122-9. Epub 2008 Aug 22. Diabetologia. 2008. PMID: 18719883
-
Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1 alpha and PPAR beta/delta gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus.Int J Obes (Lond). 2007 Aug;31(8):1302-10. doi: 10.1038/sj.ijo.0803567. Epub 2007 Feb 20. Int J Obes (Lond). 2007. PMID: 17310221 Clinical Trial.
-
Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle.Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6570-5. doi: 10.1073/pnas.0401401101. Epub 2004 Apr 20. Proc Natl Acad Sci U S A. 2004. PMID: 15100410 Free PMC article.
Cited by
-
Catalpol Ameliorates Insulin Sensitivity and Mitochondrial Respiration in Skeletal Muscle of Type-2 Diabetic Mice Through Insulin Signaling Pathway and AMPK/SIRT1/PGC-1α/PPAR-γ Activation.Biomolecules. 2020 Sep 24;10(10):1360. doi: 10.3390/biom10101360. Biomolecules. 2020. PMID: 32987623 Free PMC article.
-
Mitochondrial regulation of β-cell function: maintaining the momentum for insulin release.Mol Aspects Med. 2015 Apr;42:91-104. doi: 10.1016/j.mam.2015.01.004. Epub 2015 Feb 7. Mol Aspects Med. 2015. PMID: 25659350 Free PMC article. Review.
-
Understanding Genetic Heterogeneity in Type 2 Diabetes by Delineating Physiological Phenotypes: SIRT1 and its Gene Network in Impaired Insulin Secretion.Rev Diabet Stud. 2016 Spring;13(1):17-34. doi: 10.1900/RDS.2016.13.17. Epub 2016 May 10. Rev Diabet Stud. 2016. PMID: 27563694 Free PMC article. Review.
-
Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure.Cell Metab. 2013 Apr 2;17(4):491-506. doi: 10.1016/j.cmet.2013.03.002. Cell Metab. 2013. PMID: 23562075 Free PMC article. Review.
-
Diabetic neuropathy: A NRF2 disease?J Diabetes. 2024 Sep;16(9):e13524. doi: 10.1111/1753-0407.13524. Epub 2023 Dec 29. J Diabetes. 2024. PMID: 38158644 Free PMC article. Review.
References
-
- Eriksson, J., Franssila-Kallunki, A., Ekstrand, A., Saloranta, C., Widen, E., Schalin, C. & Groop, L. (1989) N. Engl. J. Med. 321 337-343. - PubMed
-
- Martin, B. C., Warram, J. H., Krolewski, A. S., Bergman, R. N., Soeldner, J. S. & Kahn, C. R. (1992) Lancet 340 925-929. - PubMed
-
- Ducluzeau, P. H., Perretti, N., Laville, M., Andreelli, F., Vega, N., Riou, J. P. & Vidal, H. (2001) Diabetes 50 1134-1142. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U24 DK058739/DK/NIDDK NIH HHS/United States
- DK02526/DK/NIDDK NIH HHS/United States
- DK47936/DK/NIDDK NIH HHS/United States
- R01 DK024092/DK/NIDDK NIH HHS/United States
- R01 DK047936/DK/NIDDK NIH HHS/United States
- U01 HL066582/HL/NHLBI NIH HHS/United States
- HL066582/HL/NHLBI NIH HHS/United States
- R01 DK060837/DK/NIDDK NIH HHS/United States
- DK24092/DK/NIDDK NIH HHS/United States
- P01HG01323/HG/NHGRI NIH HHS/United States
- K12 DK063696/DK/NIDDK NIH HHS/United States
- R56 DK024092/DK/NIDDK NIH HHS/United States
- RR-01346/RR/NCRR NIH HHS/United States
- DK06087/DK/NIDDK NIH HHS/United States
- DK063696/DK/NIDDK NIH HHS/United States
- M01 RR001346/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases